Search Within

Jennifer Lynn Sauter

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (14)
Groups
  1. Department of Pathology and Laboratory Medicine (29)
  2. Epidemiology and Biostatistics (29)
  3. Department of Medicine (26)
  4. Solid Tumor Oncology Division (26)
  5. Thoracic Oncology (26)
  6. GSK Faculty (24)

More Groups

People
  1. Marc Ladanyi (16)
  2. William Travis (14)
  3. Marjorie Zauderer (13)
  4. Natasha Rekhtman (12)
  5. Prasad Adusumilli (12)
  6. Hira Rizvi (11)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (1)
  4. 2022 (3)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Modern Pathology (7)
  2. Journal of Clinical Oncology (4)
  3. Laboratory Investigation (4)
  4. Clinical Cancer Research (3)
  5. Journal of Thoracic Oncology (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. Nature Research (8)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (5)
  4. American Society of Clinical Oncology (4)
  5. Nature Publishing Group (4)
  6. Cell Press (2)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression
    Meeting Abstract

    Zauderer, M.; Muller, S.; Lai, W.; Ni, A.; Jungbluth, A.; Ginsberg, M.; Daly, R.; Hellmann, M.; Ladanyi, M.; Sauter, J.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer
    Journal Article

    Hellmann, M. D.; Nathanson, T.; Rizvi, H.; Creelan, B. C.; Sanchez-Vega, F.; Ahuja, A.; Ni, A.; Novik, J. B.; Mangarin, L. M. B.; Abu-Akeel, M.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Histologic features predictive of response to PD-1 blockade in patients with non small cell lung carcinoma (NSCLC)
    Meeting Abstract

    Alex, D.; Travis, W.; Rekhtman, N.; Buonocore, D.; Ni, A.; Rizvi, H.; Hellmann, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • SMARCA4 (BRG1) deficiency in lung carcinomas correlates with poor differentiation and aggressive clinical behavior
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Beras, A.; Namakydoust, A.; Rudin, C.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Muller, S.; Zauderer, M.; Desmeules, P.; Jungbluth, A.; Fayad, M.; Frosina, D.; Ni, A.; Ladanyi, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save